CollabRx Featured on NBC News (VIDEO)
August 06, 2013 06:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured on an NBC Bay...
CollabRx Featured in Forbes Article: "Can We Build A Kickstarter For Cancer?"
August 05, 2013 09:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured a Forbes...
CollabRx, Inc. Schedules First Quarter Fiscal Year 2014 Financial Conference Call and Business Update
July 31, 2013 09:05 ET
|
CollabRx, Inc.
SAN FRANCISCO, July 31, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on August 13,...
CollabRx to Present at the 2013 Southern California Investor Conference
July 30, 2013 09:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, July 30, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
CollabRx Retains Hayden IR to Develop Strategic Investor Relations Program
July 25, 2013 16:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, July 25, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged...
CollabRx to Collaborate With the University of Chicago Medical Center on Clinical Cancer Sequencing and Interpretation
June 18, 2013 09:21 ET
|
CollabRx, Inc.
SAN FRANCISCO, June 18, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a...
CollabRx Reports Fourth Quarter and Fiscal Year 2013 Financial Results
June 03, 2013 16:00 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the fourth quarter and for the full Fiscal Year 2013, which...
CollabRx Schedules Q4 and Full Fiscal Year 2013 Financial Conference Call and Business Update
May 21, 2013 15:32 ET
|
CollabRx, Inc.
SAN FRANCISCO, May 21, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on June 3,...
CollabRx and GeneInsight to Collaborate on Interpretation and Reporting Service for Clinical Genetic Sequencing
May 08, 2013 09:01 ET
|
CollabRx, Inc.
SAN FRANCISCO and BOSTON, May 8, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing the clinical interpretation of molecular diagnostic testing, and...
CollabRx Partners With Sengenics for Molecular Diagnostics
April 09, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, April 9, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), today announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic...